EN 
MT 
DE 
FR 
ES 
IT Leading the way in life science technologies
FEEDBURNER Genetics
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc., celebrating its 40th anniversary in 2021. Renowned for its comprehensive coverage, GEN delivers exclusive insights and analysis across the life sciences, focusing on areas such as drug discovery, bioprocessing, OMICS, translational medicine, and gene editing. The magazine features high-quality reporting on the latest industry news, cutting-edge tools, and scientific advancements, making it an indispensable resource for researchers and executives.
-
Fully-Automated CGT Manufacturing Platform Jointly Being Targeted by Trenchant BioSystems and Invetech
-
Polygenic Risk Score Better Predicts Obesity and Diabetes Across Ancestries
-
ARPA-H Grants BioCurie Funds to Build Scalable Gene Therapy Manufacturing Platform
-
Vitamin B2 Pathway Identified as Potential Target for Cancer Therapy
-
StockWatch: Withdrawals, Share Prices Suggest a Still-Cloudy Outlook for IPOs